Sibofimloc Uses, Dosage, Side Effects and more
Sibofimloc is under investigation in clinical trial NCT03943446 (TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)).
| Attribute | Details |
|---|---|
| Trade Name | Sibofimloc |
| Generic | Sibofimloc |
| Sibofimloc Other Names | Sibofimloc |
| Type | |
| Formula | C35H39NO11 |
| Weight | Average: 649.693 Monoisotopic: 649.25231108 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
